In addition, a study has demonstrated that PPAR-agonists have antidiabetogenic, anti-inflammatory, and antioxidant effects, which are all potentially beneficial in the treatment of gestational diabetes mellitus (GDM) [77]. This evidence concerns the gene PPARA and gestational diabetes.